Jill Uhlenkamp, PhD

Dr. Jill Uhlenkamp has nearly 20 years of experience in immunoassay development, with more than a decade of that time spent in regulated bioanalysis for drug development including in both biotech and CRO settings. She has developed or overseen development and validation for a wide range of bioanalytical assays. Her experience includes PK, ADA, NAb, and biomarker assays; preclinical and clinical studies; and small, large and oligonucleotide-based therapeutics in a range of matrices.

At Labcorp Bioanalytical Services, Jill currently serves as the senior method development manager, overseeing the immunochemistry method development and method validation teams in the Indianapolis BioAnalytical group. Jill earned her PhD in analytical chemistry from Iowa State University.